Your browser doesn't support javascript.
loading
ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu, Jinming; Wang, Yan; Jiang, Jiahao; Yin, Cong; Shi, Bentao.
Affiliation
  • Xu J; Department of Urology, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, Guangdong, China.
  • Wang Y; Shantou University Medical College, Shantou, 515041, Guangdong, China.
  • Jiang J; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
  • Yin C; Department of Urology, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, Guangdong, China.
  • Shi B; Department of Urology, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, Guangdong, China.
J Transl Med ; 21(1): 56, 2023 01 30.
Article in En | MEDLINE | ID: mdl-36717944
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Transl Med Year: 2023 Document type: Article Affiliation country: China